Wcm Investment Management, LLC Kodiak Sciences Inc. Transaction History

Wcm Investment Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$110.45 - $164.47 $4.93 Million - $7.34 Million	-44,654 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$60.78 - $154.03 $2.03 Million - $5.13 Million	-33,322 Reduced 42.73%	44,654 $6.56 Million
Q3 2020 Nov 06, 2020	BUY	$45.05 - $59.27 $1.91 Million - $2.51 Million	42,318 Added 118.68%	77,976 $4.62 Million
Q2 2020 Aug 18, 2020	BUY	$42.74 - $66.25 $1.52 Million - $2.36 Million	35,658 New	35,658 $1.93 Million

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $433M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Wcm Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wcm Investment Management, LLC with notifications on news.